Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart(®) Injector: Results of the Prospective Cohort Study REBIFLECT

INTRODUCTION: Consistent treatment adherence is an important determinant of durable response in multiple sclerosis (MS). Published data indicate that adherence to > 80% of prescribed doses may be considered optimal. Feedback of electronic application monitoring data to patients has been considere...

Descripción completa

Detalles Bibliográficos
Autores principales: Rieckmann, Peter, Ziemssen, Tjalf, Penner, Iris-Katarina, Raji, Alaleh, Wagner, Torsten, Richter, Joachim, Zettl, Uwe K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122862/
https://www.ncbi.nlm.nih.gov/pubmed/35428903
http://dx.doi.org/10.1007/s12325-022-02100-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122862/
https://www.ncbi.nlm.nih.gov/pubmed/35428903
http://dx.doi.org/10.1007/s12325-022-02100-w

Ejemplares similares